Enhancing the efficacy of radical prostatectomy in locally advanced prostate cancer

Urologia Internationalis

Volumn 60, Issue SUPPL.2, 1998, Pages 2-10

  Altwein, J E ^a,b  

^a Department of Urology   (Germany)

^b KRANKENHAUS BARMHERZIGE BRÜDER   (Germany)

Author keywords

Locally advanced prostate cancer; Treatment options

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; FROZEN SECTION; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; MALE; NOMOGRAM; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURGICAL TECHNIQUE; SURVIVAL TIME; TUMOR BIOPSY;

EID: 0031967452     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056545     Document Type: Conference Paper

References (25)

1. Parker SL, Tong T, Bolden S, Wingo A: Cancer statistics 1997. J Clin 1997;47:5-27.
2. Frohmüller H, Theiss M, Wirth MP: Radical prostatectomy for carcinoma of the prostate: Long-term follow-up of 115 patients. Eur Urol 1991;19:279-283.
3. Kalies R, Leitenberger A, Schneider W, Altwein JE: Radikale Prostatektomie beim lymphogen metastasierten Prostatakarzinom? Akt Urol 1997;28:316-322.
4. Cadeddu JA, Partin AW, Epstein JI, Walsh PC: Stage D1CT1-3, N1-3 M0 prostate cancer: A case-controlled comparison of conservative treatment versus radical prostatectomy. Urology 1997;50:251-255.
5. Mettlin C: Changes in patterns of prostate cancer care in the United States: Results of American College of Surgeons Commission on Cancer Studies, 1974-1993. Prostate 1997,32:221-226.
6. Wasson J, Fleming C, Bruskewitz R, Albertson P, Baroy M, Yao G, Wennberg J, Littenberg B, Mulley A: The treatment of localized prostate cancer. What are we doing, what do we do, and what should we be doing? Semin Urol 1993;11:23-26.
7. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC: Comparison of digital rectal examination and serum prostate specific antigen m the early detection of prostate cancer: Results of a multicenter trial of 6.630 men. J Urol 1994;151:1283-1290.
8. Abbas F, Scardino PT: Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary. Urol Clin North Am 1996;23:587-604.
9. Stamey TA, Villers AA, McNeal JE, Link PC, Freiha FS: Positive surgical margins at radical prostatectomy: Importance of the apical dissection. J Urol 1990;143:1166-1173.
10. Levran Z, Gonzalez JA, Diokno A, Jafri SZH, Steinert BW: Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? Br J Urol 1995;75:778-781.
11. Carrol PR, Presti JC, Small E Jr, Roach M III: Focal therapy for prostate cancer 1996: Maximizing outcome. Urology 1997;49(suppl 3A): 84-94.
12. Ennis RD, Katz AE, de Vries GM, Heitjan DF, O'Toole KM, Rubin M, Buttyan R, Benson MC, Schiff PB Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay m patients with early stage prostate carcinoma. Independence from other pretreatment characteristics. Cancer 1997;79:2402-2408.
13. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC: The use of prostate specific antigen, clinical stage and Gleason score to predict pathologic stage in men with localized prostate cancer. J Urol 1993;150:10-14.
14. Partin AW, Kattan MW, Subong ENP, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA 1997;227:1445-1451.
15. Altwein JE, Wirth MP: The use of panoramic loupes in radical prostatectomies. Urol Lett Group 1991:37-41.
16. Smith RC, Partin AW, Epstein JI, Brendler CB: Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. J Urol 1996;156:454-458.
17. Stephenson RA, Middleton RG, Abbott TM: Wide excision (nonnerve sparing) radical retropubic prostatectomy using an initial perirectal dissection. J Urol 1997;157:251-255.
18. Morton RA, Steiner MS, Walsh PC: Cancer control following anatomical radical prostatectomy: An interim report. J Urol 1991;145:1197-1200.
19. Oefelein MG, Grayhack JT, McVary KT: Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate. Cancer 1995;76:2535-2542.
20. Eisbruch A, Perez CA, Roessler EH, Lockett MA: Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer 1994;73:384-388.
21. Leitenberger A, Beyer A, Schneider W, Altwein JE: Radikale Prostatektomie im Stadium pT3 pN0: Konsequenz bei positiven Schnitträndern. Urologe A 1994;33:137.
22. Aus G, Hugosson J, Norlen L: Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 1995;154:160-165.
23. Chodak GW, Thisted RA, Gerber GS, et al: Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330:242-248.
24. Bagshaw MA, Cox RS, Hancock SL: Control of prostate cancer with radiotherapy: Long-term results. J Urol 1994;152:1781-1785.
25. Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE: Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 1994;151:1315-1320.